Rheumatoid Arthritis Recruiting Phase Trials for Tofacitinib (DB08895)

Also known as: RA / Rheumatic Arthritis / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Rheumatoid Arthritis (RA) / Rheumatoid Arthritis(RA) / Arthritis, Rheumatoid (RA) / Systemic rheumatoid arthritis / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Atrophic arthritis

IndicationStatusPhase
DBCOND0027961 (Rheumatoid Arthritis)RecruitingNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03387423Observational Study to Determine How Physicians Make Treatment Decisions in Patients Treated With Tofacitinib for Moderate to Severe Active Rheumatoid Arthritis
NCT03981900IDentification of Factors Predictive of Tofacitinib's Survival in Patient With Rheumatoid Arthritis
NCT03440892Effects of Antirheumatic Treatment on Levels of Survivin in Rheumatoid Arthritis Patients
NCT03011281Effectiveness and Safety of Tofacitinib in Korean Patients With Rheumatoid Arthritis